The metabolism of lipoprotein (a): an ever-evolving story

The metabolism of lipoprotein (a): an ever-evolving story

Lipoprotein (a) [Lp(a)] is characterized by apolipoprotein (a) [apo(a)] covalently bound to apolipoprotein B 100. It was described in human plasma by Berg et al. in 1963 and the gene encoding apo(a) (LPA) was cloned in 1987 by Lawn and colleagues. Epidemiologic and genetic studies demonstrate that i...

Full description

Bibliographic Details
Main Authors:	Gissette Reyes-Soffer, Henry N. Ginsberg, Rajasekhar Ramakrishnan
Format:	Article
Language:	English
Published:	Elsevier 2017-09-01
Series:	Journal of Lipid Research
Subjects:	apolipoproteins atherosclerosis clinical trials low density lipoprotein/metabolism lipoproteins/kinetics human studies
Online Access:	http://www.sciencedirect.com/science/article/pii/S002222752033947X

Similar Items

Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
by: Michael B. Boffa, et al.
Published: (2016-05-01)

Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review
by: Alexia Rouland, et al.
Published: (2022-12-01)

Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor
by: Danijela Lucic, et al.
Published: (2007-02-01)

Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
by: Bi-lian Yu, et al.
Published: (2012-09-01)

Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
by: Chih-Kuo Lee, et al.
Published: (2021-08-01)

ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
by: Katherine Olin-Lewis, et al.
Published: (2002-11-01)

Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice
by: Shiqiang Qiu, et al.
Published: (1998-08-01)

Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes[S]
by: Ying Zhang, et al.
Published: (2016-02-01)

Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
by: Feroz Ahmad, et al.
Published: (2021-09-01)

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma
by: David Meriwether, et al.
Published: (2011-10-01)

Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency
by: Katsunori Ikewaki, et al.
Published: (2004-07-01)

Serum lipoprotein accumulation in the livers of orotic acid-fed rats
by: LAWRENCE A. POTTENGER, et al.
Published: (1971-07-01)

Effect of weight loss, independent of change in diet composition, on apolipoprotein AI kinetic in men with metabolic syndrome
by: Caroline Richard, et al.
Published: (2013-01-01)

High-Density Lipoprotein and Heart Failure
by: Liyun Xing, et al.
Published: (2023-11-01)

Alginic acid cell entrapment: a novel method for measuring in vivo macrophage cholesterol homeostasis
by: Timothy J. Sontag, et al.
Published: (2015-02-01)

Comparison of the metabolic behavior in vitro of the apoproteins of rat serum high density lipoprotein2 and high density lipoprotein3
by: Bernard Rubenstein, et al.
Published: (1973-05-01)

Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review
by: C. Roger White, et al.
Published: (2014-10-01)

The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus
by: William L. Isley, et al.
Published: (2006-01-01)

High density lipoproteins and atherosclerosis II /
by: International Symposium on High Density Lipoproteins and Atherosclerosis (2nd : 1988 : Maidstone, England), et al.
Published: (1989)

Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractionss⃞
by: Zheng Chunyu, et al.
Published: (2007-05-01)

Developing Electron Microscopy Tools for Profiling Plasma Lipoproteins Using Methyl Cellulose Embedment, Machine Learning and Immunodetection of Apolipoprotein B and Apolipoprotein(a)
by: Yvonne Giesecke, et al.
Published: (2020-09-01)

High‐Density Lipoprotein Subspecies Defined by Apolipoprotein C‐III and Subclinical Atherosclerosis Measures: MESA (The Multi‐Ethnic Study of Atherosclerosis)
by: Sarah A. Aroner, et al.
Published: (2018-03-01)

ApoE genotype-specific inhibition of apoptosis
by: Robert M. DeKroon, et al.
Published: (2003-08-01)

The role of level and function of High Density Lipoprotein (HDL) in Cardiovascular Diseases
by: Malihe Aghasizadeh, et al.
Published: (2020-06-01)

Coronary risk prediction by the correlation of total cholesterol/high-density lipoprotein, triglyceride/high-density lipoprotein, low-density lipoprotein/high-density lipoprotein ratios, non-high-density lipoprotein, apolipoprotein-B, and high-sensitivity C-reactive protein with low-density lipoprotein in Indian patients under statin therapy
by: A K Badrinath, et al.
Published: (2019-01-01)

Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide
by: Gunilla Nordin Fredrikson, et al.
Published: (2006-09-01)

Concentration of apolipoprotein-E in high-density lipoproteins of human blood plasma
by: Kaneva Anastasiya M., et al.
Published: (2013-01-01)

Characterization of the plasma lipoproteins of the genetically obese hyperlipoproteinemic Zucker fatty rat
by: Gustav Schonfeld, et al.
Published: (1974-09-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

Circulating oxidized LDL, increased in patients with acute myocardial infarction, is accompanied by heavily modified HDL[S]
by: Naoko Sawada, et al.
Published: (2020-06-01)

Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis
by: Belinda A. Di Bartolo, et al.
Published: (2016-06-01)

Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding
by: Allan D. Sniderman, et al.
Published: (2018-01-01)

Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome
by: Esther M.M. Ooi, et al.
Published: (2012-11-01)

The ratio of low-density lipoprotein cholesterol to apolipoprotein-B as a marker of low-density lipoprotein particle size
by: A. M. Kaneva, et al.
Published: (2018-06-01)

Efficacy and Safety of High-Density Lipoprotein/Apolipoprotein A1 Replacement Therapy in Humans and Mice With Atherosclerosis: A Systematic Review and Meta-Analysis
by: Ayiguli Abudukeremu, et al.
Published: (2021-08-01)

Characterization of apoM in normal and genetically modified mice
by: Kirsten Faber, et al.
Published: (2004-07-01)

Lipoprotein apheresis to treat elevated lipoprotein (a)1
by: Elisa Waldmann, et al.
Published: (2016-10-01)

ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins
by: Richard B. Weinberg, et al.
Published: (2012-04-01)

Enhancement of High-Density Lipoprotein (HDL) Quantity and Quality by Regular and Habitual Exercise in Middle-Aged Women with Improvements in Lipid and Apolipoprotein Profiles: Larger Particle Size and Higher Antioxidant Ability of HDL
by: Kyung-Hyun Cho, et al.
Published: (2023-01-01)

Long-Term Alcohol Consumption Caused a Significant Decrease in Serum High-Density Lipoprotein (HDL)-Cholesterol and Apolipoprotein A-I with the Atherogenic Changes of HDL in Middle-Aged Korean Women
by: Kyung-Hyun Cho, et al.
Published: (2022-08-01)